Trump's Russian Diesel Deal Collides With the Graham Act's October 18 Deadline
Speaking to reporters at the White House on October 13 before leaving for a campaign trip to Youngstown, Ohio, President Trump dismissed Republican senators who oppose his Russian diesel arrangement as people who "can't really be serious" — and then floated a measure that would hit his own refiners:
- "We could do a restriction on oil, but the rest of the world would be greatly, greatly affected if we do that. We could do a restriction, you know, a cap on diesel, keep it all for ourselves. That would have a very big impact."
- "It's not really a deal with me; it's a deal for the rest of the world. So, anything that could help our farmers or ranchers, I like."
The law behind the deadline is the Lindsey O. Graham Sanctioning Russia and Iran Act, which Trump signed on September 18, 2026 (passed the Senate 86-11 and the House 262-159).
- Section 112 requires the president to raise duties on all goods imported from Russia, explicitly including petroleum and petroleum products, to a rate of up to 500% within 30 days of enactment. The thirtieth day is Sunday, October 18; several law firms advising clients give the operative date as Monday, October 19.
- Section 113 provides additional duties of up to 100% on all goods from the five largest buyers of Russian crude or gas — but only if they knowingly make new purchases on or after that deadline. Purchases made before it do not count, whatever has been said about them.
- Section 113(g) requires the president or USTR to send the relevant congressional committees a written justification not later than 10 days before imposing a duty. For a October 18 start, that fell around October 8. As of October 12-13 the administration had published no target list, no rate and no waiver.
- The present collision: a Treasury General License 135, issued October 9, permits Russian diesel into the United States until April 7, 2027. Because it was issued after the September 18 enactment, the Act's Section 114(h)(1) shelter for pre-existing licences does not cover it, while Section 112 says the president "shall" act.
- Senator Thom Tillis has said the arrangement may breach the 2022 ban on Russian oil imports; the backlash in Congress is bipartisan.
| Stock | Impact | Reason | Confidence |
|---|---|---|---|
| VLO, PSX, MPC | 🔴 Negative | Both halves of this policy push the same way for US refiners: an import licence adds product into the domestic diesel market, and an export cap would remove the outlet that has carried distillate cracks all quarter | 3/5 |
| XOM, CVX | 🟡 Watch | The integrateds are marked to crude above $100 through the upstream, but their refining arms face the same crack compression as the pure-play refiners | 2/5 |
| DAL, UAL, AAL, LUV | 🟢 Positive | The deal is explicitly framed as easing prices at the pump ahead of the November 3 midterms; cheaper distillate is the largest single line-item relief for airline fuel bills | 2/5 |
| SAVE | 🟡 Watch | Same fuel logic as the majors, but the balance sheet is the binding constraint on this name rather than the crack spread | 2/5 |
Trump Media Pulls Three Crypto ETF Filings as Its Political Badge Reprices
Yorkville America, the sponsor and investment adviser for the Truth Social funds, withdrew registration statements on October 13 for the Truth Social Bitcoin ETF, the Truth Social Bitcoin & Ethereum ETF and the Truth Social Crypto Blue Chip ETF.
- Trump Media & Technology Group told the SEC it "has determined to withdraw the Registration Statement and not to pursue the public offering at this time," describing the move as a structural reset from a 1933 Act product to a 1940 Act structure.
- Bloomberg Intelligence's James Seyffart questioned the rationale: "Of course a 33 Act ETP is different from a 40 Act ETF and it has less protections. Anyone in this space knows that. Nothing has changed."
- The more plausible driver is competition. Morgan Stanley's MSBT Bitcoin spot ETF charges 0.14%, the lowest on the market, and has taken in more than $230 million without a single day of net outflows. The first five Truth Social ETFs have gathered just over $30 million in combined assets since launching at the end of 2025.
- Separately, on-chain data cited by market observers showed TMTG moved 2,650 Bitcoin, about $205 million, to Crypto.com. The company posted a $405.9 million first-quarter net loss, largely non-cash marks on digital assets.
- The stock fell roughly 5% on October 13 to about $8.2, from a prior close of $8.65, and is down about 42% year-to-date. The proximate driver was political rather than operational: a Reuters/Ipsos poll put Trump's approval rating at 32%, the lowest of his career and down from 35% a week earlier.
| Stock | Impact | Reason | Confidence |
|---|---|---|---|
| DJT | 🔴 Negative | ✅ named. A withdrawn product filing removes the last identifiable B2B revenue catalyst from the story while the political asset that underpins the valuation is being re-rated down | 3/5 |
| MS | 🟢 Positive | ✅ named. The 0.14% fee wrapper is doing to crypto ETFs what index funds did to active management — the incumbent with the cheapest product is the one collecting the flow | 3/5 |
| BLK, COIN | 🟡 Watch | A well-capitalised issuer walking away from the category is a competitive signal, not a volume signal: the fee war is now the entry barrier | 2/5 |
The Third Quarter Opens With a Split: Goldman's Trading Blowout, JPMorgan's First Miss in Three Years
Four of the largest US banks reported on October 13, and the spread between them was the story of the session.
- Goldman Sachs earned $17.01 a share, against roughly $13.02 expected, on net income of $5.29 billion (+29% year on year). Revenue rose 23% to $18.68 billion, its second-best quarter ever, about $2 billion above consensus. Equities revenue jumped 72% to $6.44 billion and investment banking fees rose 21% to $3.22 billion, while fixed income slipped about 1% to $3.47 billion.
- JPMorgan Chase posted net income of $15.31 billion, or $5.57 a share, missing estimates of $5.90. Revenue of $50.91 billion came in below the $51.22 billion expected. A $658 million loss on investment securities cut $0.18 from EPS; excluding it, earnings were $5.75. Equity markets revenue rose 49% to $5.0 billion while fixed income fell 4% to $5.4 billion, roughly $550 million below estimates. Expenses grew 12% over twelve months against revenue growth of 8%, and provisions were inflated by a $2.2 billion charge tied to the Apple Card portfolio deal.
- Citigroup beat estimates; Wells Fargo missed on revenue. JPMorgan shares were up about 0.8% early, Goldman up 1.9%.
- Jamie Dimon's statement is the one worth keeping: "The U.S. economy continued to be fueled by strong business investment and ongoing consumer spending. However, large fiscal deficits, sticky inflation, elevated asset prices, rising interest rates and geopolitical conditions continue to shift under the surface."
- Context: global investment banking revenue fell 6.6% year on year to $27.2 billion in the quarter as closed mergers and debt issuance declined, and the S&P 500 Banks Index fell 5.4% in the third quarter against a 2.3% gain for the S&P 500.
| Stock | Impact | Reason | Confidence |
|---|---|---|---|
| GS | 🟢 Positive | ✅ named. A 72% surge in equities revenue is the cleanest read on how much of the 2026 Wall Street boom is trading-desk rather than deal-fee driven | 4/5 |
| JPM | 🟡 Watch | ✅ named. A rare miss driven by fixed income and a securities loss is a quality-of-earnings question more than a franchise question, and the shares held anyway | 3/5 |
| C | 🟢 Positive | ✅ named. A beat supports the relative-value trade into the cheaper large-cap bank balance sheets | 3/5 |
| WFC | 🔴 Negative | ✅ named. A revenue miss reinforces the asset-cap and deposit-cost constraints that have kept this name a laggard through the rate cycle | 3/5 |
The Memory Rout Crosses the Pacific and Reaches US Chip Names
The trigger was in China, but the selling landed in US semis first.
- China's ChangXin Memory Technologies (CXMT) said it will mass-produce DDR5 RDIMM built on a 4F² DRAM cell architecture by year-end, a structure that cuts cell area by roughly 30%. The claim has not been independently verified. CXMT president Cao Kanyu set it out at an industry conference in Shanghai over the weekend.
- The Philadelphia Semiconductor Index fell 2.67% overnight, with Micron down 3.88%, Intel down 3.20%, Broadcom down 1.88%, SanDisk down 5.97% and Seagate down 3.80%.
- Capital costs are compounding the supply fear. Broadcom CEO Hock Tan, speaking in Singapore on October 12, said "the biggest constraint in AI expansion is capital," and Intel CEO Lip-Bu Tan said "the biggest challenge is capital and the cost of capital."
- In the US session on October 13 the Dow was up while the Nasdaq was lower, with memory names under pressure — a rotation inside the index rather than a broad risk-off move.
| Stock | Impact | Reason | Confidence |
|---|---|---|---|
| MU, WDC, STX | 🔴 Negative | A credible 4F² DRAM roadmap from a Chinese producer attacks the memory pricing cycle directly, and these are the US-listed names with the most direct DRAM and NAND price exposure | 4/5 |
| AVGO, AMD | 🔴 Negative | Both are re-rated as AI beneficiaries; when memory supply expectations shift, the entire accelerator complex is marked against a lower scarcity premium | 3/5 |
| INTC | 🔴 Negative | Still in a capital-intensive turnaround, so a market that is newly sceptical of capital-heavy semiconductor models is the wrong backdrop | 3/5 |
| MSFT, GOOGL, AMZN | 🟢 Positive | ⚠️ inferred. The buyers of memory and accelerators are the beneficiaries of any easing in component pricing, which is why hyperscaler margins move opposite to chip prices | 2/5 |
Medicaid and CHIP Stop Paying for Gender Care for Minors
A CMS final rule took effect on October 13, 2026, ending federal Medicaid and Children's Health Insurance Program funding for puberty blockers, cross-sex hormones and surgical procedures for minors.
- Medicaid applies the restriction to children under 18, CHIP to those under 19. Mental-health services remain covered, states may still fund excluded treatments from their own budgets, and minors already on hormone therapy get a tapering period of up to six months, phasing out by April 2027.
- CMS said an HHS review found "significant gaps" in the supporting evidence and cited risks including infertility, impaired sexual function and reduced bone density. Administrator Mehmet Oz called the interventions "experimental" with "no proven benefits."
- The rule was finalised on August 13, 2026 and traces to the January 2025 executive order directing agencies to restrict federal support for these procedures.
| Stock | Impact | Reason | Confidence |
|---|---|---|---|
| CNC, MOH | 🟡 Watch | ⚠️ inferred. These are the most Medicaid-levered listed managed-care names, so a coverage exclusion removes lives and premium revenue while removing very little claims cost | 2/5 |
| UNH, ELV, CI | 🟡 Watch | ⚠️ inferred. Medicaid is a smaller share of these diversified books, and the excluded services are a rounding error against total medical spend | 2/5 |
| HCA, THC, UHS | 🟡 Watch | ⚠️ inferred. Procedure volumes in the affected categories are a very small fraction of hospital revenue, and mental-health coverage is unchanged, which matters more to these operators | 2/5 |
A Tariff-Refund Class Action Gets Certified, and CPI Lands Tomorrow
- Judge Richard Eaton of the US Court of International Trade certified a class action brought by Freestyle World Inc. on behalf of every importer that paid IEEPA tariffs between February 1, 2025 and February 19, 2026, following the Supreme Court's February ruling in Learning Resources, Inc. v. Trump, 146 S. Ct. 628 (2026). The government collected an estimated $166 billion from roughly 330,000 importers; CBP has refunded about $126 billion with interest through its CAPE system. Eaton held a closed conference with the parties on October 13 and ordered a proposed schedule by October 22.
- September US CPI lands October 14 at 8:30 a.m. ET, the last inflation print before the October 27-28 FOMC. Consensus: headline +0.6% month on month and 3.7% year on year (from 0.4% and 3.4%), core +0.2% and 2.4-2.5%. Energy is expected to contribute about 5.5%, led by gasoline. CME FedWatch prices roughly a 19% chance of an October hike against about 85% for December, and Fed Chair Warsh speaks on Friday.
- The tape, mid-session — not a close. At the open on October 13 the S&P 500 was near 7,800 (about -0.1%), the Dow near 51,853 and the Nasdaq near 27,214. By 10:31 a.m. ET the Dow was up roughly 0.6% while the Nasdaq was down about 0.3%. The prior session (October 12) closed at S&P 500 7,807.24, down 0.06%. The 10-year Treasury yield sat near 5.19-5.24% (its lowest since October 2) and the dollar index near 102.3, off an 18-month high.
| Stock | Impact | Reason | Confidence |
|---|---|---|---|
| WMT, TGT, AMZN, HD, LOW | 🟢 Positive | The certification converts a scattered set of individual suits into a single route for tens of thousands of importers, and the largest importers carry the largest refund claims | 3/5 |
| NKE, DKS, ETSY | 🟢 Positive | ⚠️ inferred. A second-order beneficiary: smaller importers that could not afford to litigate individually now recover duty costs that had been absorbed into gross margin | 2/5 |
| XLF (banks) | 🟡 Watch | A core CPI print at 0.3% or above would revive back-to-back hike pricing and steepen the front end; an in-line 0.2% keeps the curve range-bound into the Fed | 2/5 |
Policy Pulse — Trump / US Watch. Every headline above carries a stock-level inference; where a mapping is inferred rather than named it is marked ⚠️ and scored accordingly. No buy or sell recommendation is made — direction and confidence only. The US session was still open when this edition was written, so US index levels are intraday and the prior close is stated explicitly.